CAS 361440-67-7 Maʻemaʻe >98.5% (HPLC) Hale Hana
ʻO Ruifu Chemical Supply pili i waena
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Inoa Kimia | (1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester |
Nā huaʻōlelo like | N-Boc-L-cis-4,5-Methanoprolineamide;N-Boc-cis-4,5-Methano-L-Prolinamide;tert-Butyl (1S,3S,5S)-3-Carbamoyl-2-Azabicyclo[3.1.0]hexane-2-Carboxylate |
Helu CAS | 361440-67-7 |
Helu CAT | RF-PI1990 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C11H18N2O3 |
Kaumaha Molecular | 226.27 |
Lae paila | 388.9±21.0℃ |
ʻO ka mānoanoa | 1.228 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Pauda keʻokeʻo |
Maʻemaʻe / Kaʻina Hanana | >98.5% (HPLC) |
Nalo ma ka maloo | <0.50% |
Koena ma ka Ignition | <0.20% |
Nā haumia pākahi | <1.00% |
Huina paumaele | <1.50% |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Waena o API (CAS: 361442-04-8) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester (CAS: 361440-67-7) mea waena o API (CAS: 361442 -04-8).(CAS: 361442-04-8) he lāʻau hypoglycemic waha (anti-diabetic drug) o ka dipeptidyl peptidase-4 (DPP-4) papa o nā lāʻau.ʻO ka hoʻomohala mua ʻana na Bristol-Myers Squibb wale nō;ma 2007 hui pū ʻo AstraZeneca me Bristol-Myers Squibb e hoʻomohala pū i ka hui hope loa a hui pū i ke kūʻai ʻana i ka lāʻau.I Iune 2008, ua hoʻolaha ʻia ʻo Onglyza ka inoa kālepa e kūʻai ʻia ai.Hoʻohana ʻia ʻo API (CAS: 361442-04-8) ma ke ʻano he monotherapy a i hui pū ʻia me nā lāʻau lapaʻau ʻē aʻe no ka mālama ʻana i ka maʻi diabetes type 2.Hoʻopili koke ʻia ma hope o ka hoʻokele waha a loaʻa iā ia kahi ʻōlelo pharmacokinetic kūpono me ka hoʻohana ʻana i hoʻokahi manawa i kēlā me kēia lā.Hoʻokani ia i ka hana ma o ke kāohi ʻana i ka hoʻohaʻahaʻa GLP-l.ʻO GLP-I nā hormones i hana maoli ʻia i loko o ka ʻōpū ma hope o ka ʻai ʻana i ka meaʻai.